awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Table
SPARQL
Graphs
1
1
Services
1
1
Assets
0
0
Insights
Schema
BETA
Class frequency
Class hierarchy
Q38826804-61F3F2A6-1F7F-40AC-8D33-DAD41EAE37F8
Q38826804-61F3F2A6-1F7F-40AC-8D33-DAD41EAE37F8
BestRank
Statement
http://www.wikidata.org/entity/statement/Q38826804-61F3F2A6-1F7F-40AC-8D33-DAD41EAE37F8
Immunotherapeutic strategies in antiphospholipid syndrome.
P2860
Q38826804-61F3F2A6-1F7F-40AC-8D33-DAD41EAE37F8
BestRank
Statement
http://www.wikidata.org/entity/statement/Q38826804-61F3F2A6-1F7F-40AC-8D33-DAD41EAE37F8
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
dd49aaba44941ee414505bc01c6c8f2efe673bc7
P2860
Eculizumab Induces Sustained Remission in a Patient With Refractory Primary Catastrophic Antiphospholipid Syndrome.